All Stories

  1. Chronic rhinosinusitis: a qualitative study of patient and clinician experiences of the MACRO randomised controlled trial of surgical versus medical management
  2. Comparing quality of life in smell and taste disorders with other chronic conditions – a narrative review
  3. Investigating the Effect of Tumour Necrosis Factor Antagonist on Olfaction
  4. A Cross‐Sectional Study Exploring Patient Experiences, Unmet Needs and Desired Support in Those With Olfactory Dysfunction
  5. A Prospective Cohort Study Investigating the Role of a Screening Smell and Taste Test in Patients Following Head Injury
  6. The APOLLO Trial: A P roof-of-Concept Study for Vitamin A Nasal Drops in COVID-19 Related Post-Infectious Ol factory Dysfunction
  7. Digital intervention for smell training: a real-world study on engagement, adherence, and behavioural dynamics
  8. Investigating idiopathic anosmia as a prodromal state of Parkinson’s disease
  9. The need to promote smell health across the globe
  10. Endoscopic Management of Sinus Neoplasia: An Experience of a Dedicated Sinus Centre in Image-Guided Surgery of Inverted Papillomata
  11. A trial comparing sinus surgery and antibiotics in adults with chronic rhinosinusitis
  12. The need to promote smell health across the globe
  13. Exploring barriers to seeking support for Smell and Taste Disorders (SATDs) amongst minority communities in the UK
  14. Gustatory dysfunction in dementia and cognitive decline
  15. Olfactory loss and dysfunction in dementia and cognitive decline
  16. A New Approach to Dementia
  17. \fancyhead [R] Smell and Taste Disorder Impact on Eating Habits: a cross-sectional observational study
  18. The Development and Validation of the Smell‐Qx Questionnaire, Based on a Systematic Review of the Literature and the COMET Initiative on the Development of Core Outcome Sets for Clinical Trials in Olfactory Disorders
  19. Epidemiology of Cholesteatoma in the UK Biobank
  20. British Skull Base Society Consensus on Vestibular Schwannoma Surveillance
  21. Nasal endoscopy score thresholds to trigger consideration of chronic rhinosinusitis treatment escalation and implications for disease control
  22. Epidemiology of Cholesteatoma in the UK Biobank
  23. Smell Above All: Envisioning Smell-Centred Future Worlds
  24. Impact of olfactory disorders on personal safety and well-being: a cross-sectional observational study
  25. Evaluation of Hyperbaric Oxygen Therapy as an Adjuvant Treatment for Necrotising Otitis Externa: Retrospective, observational, case-control study.
  26. The Clinical Course of Paranasal Sinus Mucocoeles—A Retrospective Case Series
  27. Obesity and Olfaction
  28. Abstracts from the 56th European Society of Human Genetics (ESHG) Conference: Hybrid Posters
  29. International clinical assessment of smell: An international, cross‐sectional survey of current practice in the assessment of olfaction
  30. EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care
  31. Delivery of Topical Drugs to the Olfactory Cleft
  32. Endoscopic management of sinus neoplasia: case series of image-guided surgery of inverted papillomata and recommended best practice for managing cases.
  33. Everything smells like poo, landfill, and rotten food”: A retrospective case report using Clinical Emotional Freedom Techniques (EFT) for parosmia following COVID-19
  34. A double-blinded randomised controlled trial of vitamin A drops to treat post-viral olfactory loss: study protocol for a proof-of-concept study for vitamin A nasal drops in post-viral olfactory loss (APOLLO)
  35. Position paper on olfactory dysfunction: 2023
  36. Consensus criteria for chronic rhinosinusitis disease control: an international Delphi Study
  37. Prevalence and Associated Factors of Medication Non-Adherence in CRS Patients following Endoscopic Sinus Surgery
  38. Understanding the Impact of Chronic Rhinosinusitis with Nasal Polyposis on Smell and Taste: An International Patient Experience Survey
  39. Assessment of COVID-19-related olfactory dysfunction and its association with psychological, neuropsychiatric, and cognitive symptoms
  40. Exploring Endotypes in Chronic Rhinosinusitis (ExpRess): Protocol for a cohort study
  41. Systematic Review of Protein Biomarkers in Adult Patients With Chronic Rhinosinusitis
  42. Impact of olfactory disorders on personal safety & wellbeing: a cross-sectional observational study
  43. Developing a core outcome set for clinical trials in olfactory disorders: a COMET initiative
  44. Nose Gym: An Interactive Smell Training Solution
  45. Olfactory Nomenclature: An Orchestrated Effort to Clarify Terms and Definitions of Dysosmia, Anosmia, Hyposmia, Normosmia, Hyperosmia, Olfactory Intolerance, Parosmia, and Phantosmia/Olfactory Hallucination
  46. Whole exome sequencing study identifies candidate loss of function variants and locus heterogeneity in familial cholesteatoma
  47. Health-Related Quality of Life Impairment Among Patients with Severe Chronic Rhinosinusitis with Nasal Polyps in the SINUS-24 Trial
  48. Commentary on Patient Advocacy and Research Priorities in Olfactory and Gustatory Disorders
  49. Olfactory Disorders Questionnaire: Scaling severity of quality‐of‐life impact
  50. The Nose and the Effects of SARS-CoV-2 Pandemic
  51. The growing burden of long COVID in the United Kingdom: Insights from the UK Coronavirus Infection Survey
  52. The EUFOREA pocket guide for chronic rhinosinusitis
  53. High prevalence of persistent smell loss and qualitative smell dysfunction during the coronavirus disease 2019 (COVID‐19) pandemic in the United States: Urgent need for clinical trials
  54. Investigations and Outcomes for Olfactory Disorders
  55. Manipulation under anaesthesia of fractured nasal bones – a 10-year retrospective study
  56. The burden of olfactory dysfunction during the COVID-19 pandemic in the United Kingdom
  57. Ask the Experts: An International Consensus on Managing Post-Infectious Olfactory Dysfunction Including COVID-19
  58. Establishing UK research priorities in smell and taste disorders: A James Lind alliance priority setting partnership
  59. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction
  60. The use of MRI in a tertiary smell and taste clinic: Lessons learned based on a retrospective analysis
  61. Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): In‐depth sinus surgery analysis
  62. Whole exome sequencing study identifies candidate loss of function variants and locus heterogeneity in familial cholesteatoma
  63. The COVANOS trial – insight into post-COVID olfactory dysfunction and the role of smell training
  64. When is Magnetic Resonance Imaging most beneficial in olfactory dysfunction? A retrospective review of a tertiary referral smell and taste clinic
  65. Establishing UK Research Priorities In Smell and Taste Disorders: A James Lind Alliance Priority Setting Partnership
  66. A follow-up on quantitative and qualitative olfactory dysfunction and other symptoms in patients recovering from COVID-19 smell loss
  67. International consensus statement on allergy and rhinology: Olfaction
  68. Effects of fluid and drinking on pneumonia mortality in older adults: A systematic review and meta-analysis
  69. Interventions for the treatment of persistent post-viral olfactory dysfunction
  70. Observational retrospective study calculating health service costs of patients receiving surgery for chronic rhinosinusitis in England, using linked patient-level primary and secondary care electronic data
  71. Olfaction and CSF Leak
  72. 918 Nasal Packing Duration in The Management of Epistaxis: A Cohort Study
  73. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction
  74. Cultural Adaptation and Validity of the Sniffin’ Sticks Psychophysical Test for the UK Setting
  75. Barriers to effective health care for patients who have smell or taste disorders
  76. Patient perspectives about participation in a chronic rhinosinusitis trial during the COVID pandemic: a qualitative study.
  77. Clinical Olfactory Working Group consensus statement on the treatment of postinfectious olfactory dysfunction
  78. British Rhinological Society Consensus Guidance on the use of biological therapies for chronic rhinosinusitis with nasal polyps
  79. Socioeconomic, comorbidity, lifestyle, and quality of life comparisons between chronic rhinosinusitis phenotypes
  80. Systemic corticosteroids in coronavirus disease 2019 (COVID‐19)‐related smell dysfunction: an international view
  81. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction
  82. International consensus statement on allergy and rhinology: rhinosinusitis 2021
  83. Barriers to Effective Healthcare for Patients Who Have Smell or Taste Disorders
  84. British Rhinological Society Consensus Guidance on the use of biological therapies for Chronic Rhinosinusitis with Nasal Polyps
  85. Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction
  86. Admission avoidance in acute epistaxis: A prospective national audit during the initial peak of the COVID‐19 pandemic
  87. Health-Related Quality of Life Impairment Among Patients With Severe Chronic Rhinosinusitis With Nasal Polyps in the SINUS-24 Trial
  88. Evaluation of Smoking as a Modifying Factor in Chronic Rhinosinusitis
  89. Paediatric tonsillectomy in England: A cohort study of clinical practice and outcomes using Hospital Episode Statistics data (2008‐2019)
  90. Maximising recruitment to a randomised controlled trial for chronic rhinosinusitis using qualitative research methods: the MACRO conversation study
  91. A systematic review to examine the relationship between objective and patient‐reported outcome measures in sinonasal disorders: recommendations for use in research and clinical practice
  92. Qualitative Olfactory Disorders: Patient Experiences and Self-Management
  93. Corrigendum to: More Than Smell—COVID-19 Is Associated With Severe Impairment of Smell, Taste, and Chemesthesis
  94. Patient Experiences of Postinfectious Olfactory Dysfunction
  95. Recent Smell Loss Is the Best Predictor of COVID-19 Among Individuals With Recent Respiratory Symptoms
  96. Course of symptoms for loss of sense of smell and taste over time in one thousand forty‐one healthcare workers during the Covid‐19 pandemic: Our experience
  97. Admission avoidance in tonsillitis and peritonsillar abscess: A prospective national audit during the initial peak of the COVID‐19 pandemic
  98. Comparison of COVID-19 and common cold chemosensory dysfunction
  99. Parosmia is Associated with Relevant Olfactory Recovery After Olfactory Training
  100. Socioeconomic, comorbidity, lifestyle and quality of life comparisons between chronic rhinosinusitis phenotypes: Data from the National Chronic Rhinosinusitis Epidemiology Study
  101. Patient Experiences of Post-Infectious Olfactory Dysfunction
  102. Management of new onset loss of sense of smell during the COVID‐19 pandemic ‐ BRS Consensus Guidelines
  103. Is loss of sense of smell a diagnostic marker in COVID‐19: A systematic review and meta‐analysis
  104. Smoking as a modifying factor in chronic rhinosinusitis: Data from the Chronic Rhinosinusitis Epidemiology Study
  105. Olfactory Loss of Function as a Possible Symptom of COVID-19
  106. Defining appropriateness criteria for endoscopic sinus surgery in the management of adult dental implant patients with incidental maxillary sinus findings on conebeam computed tomography
  107. Anosmia and hyposmia in health-care workers with undiagnosed SARS-CoV-2 infection
  108. The best COVID-19 predictor is recent smell loss: a cross-sectional study
  109. Barriers to accessing healthcare in patients with olfactory and gustatory disorders
  110. Qualitative Olfactory Disorders: Patient experiences and self-management
  111. More Than Smell—COVID-19 Is Associated With Severe Impairment of Smell, Taste, and Chemesthesis
  112. Management of new onset anosmia during the COVID pandemic - BRS Consensus Guidelines
  113. Parosmia is associated with relevant olfactory recovery after olfactory training
  114. The impact of patients losing their sense of smell
  115. Anosmia as a presenting symptom of SARS-CoV-2 infection in healthcare workers – A systematic review of the literature, case series, and recommendations for clinical assessment and management
  116. Cholesteatoma and family history: An international survey
  117. The Socioeconomic Cost of Chronic Rhinosinusitis Study
  118. Biologics for chronic rhinosinusitis
  119. European Position Paper on Rhinosinusitis and Nasal Polyps 2020
  120. Biologics for chronic rhinosinusitis
  121. An unmet need: Patients with smell and taste disorders
  122. 139 Risk of parkinson’s in idiopathic anosmia
  123. Lacrimal sac primary squamous cell carcinoma with synchronous tonsillar primary squamous cell carcinoma
  124. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
  125. Antibiotic usage in chronic rhinosinusitis: analysis of national primary care electronic health records
  126. Optimising trial outcomes and patient retention for the MACRO trial for chronic rhinosinusitis
  127. The genetics of cholesteatoma study. Loss‐of‐function variants in an affected family
  128. What is the most appropriate treatment for chronic rhinosinusitis?
  129. Validation of the olfactory disorders questionnaire for English‐speaking patients with olfactory disorders
  130. EPOS2020: development strategy and goals for the latest European Position Paper on Rhinosinusitis
  131. Exploring the association between ingestion of foods with higher potential salicylate content and symptom exacerbation in chronic rhinosinusitis. Data from the National Chronic Rhinosinusitis Epidemiology Study
  132. Clarithromycin and endoscopic sinus surgery for adults with chronic rhinosinusitis with and without nasal polyps: study protocol for the MACRO randomised controlled trial
  133. Expert panel process to optimise the design of a randomised controlled trial in chronic rhinosinusitis (the MACRO programme)
  134. Chronic rhinosinusitis: a qualitative study of patient views and experiences of current management in primary and secondary care
  135. Unilateral visual loss resulting from orbital encroachment of an ethmoidal juvenile trabecular ossifying fibroma
  136. Risk of mortality and cardiovascular events following macrolide prescription in chronic rhinosinusitis patients: a cohort study using linked primary care electronic health records
  137. EPOS2020: development strategy and goals for the latest European Position Paper on Rhinosinusitis
  138. Wooden spatula sinusitis following maxillary expansion surgery
  139. Management strategies for chronic rhinosinusitis: a qualitative study of GP and ENT specialist views of current practice in the UK
  140. Topical and systemic antifungal therapy for chronic rhinosinusitis
  141. Development of an International Odor Identification Test for Children: The Universal Sniff Test
  142. Prevalence of asthma, aspirin sensitivity and allergy in chronic rhinosinusitis: data from the UK National Chronic Rhinosinusitis Epidemiology Study
  143. Saline irrigation for allergic rhinitis
  144. Faculty of 1000 evaluation for Monoclonal antibodies for the treatment of chronic rhinosinusitis with nasal polyposis: a systematic review.
  145. Eustachian tube symptoms are frequent in chronic rhinosinusitis and respond well to endoscopic sinus surgery
  146. Endonasal Approaches to Maxillary Sinus
  147. The use of nasal sprays and rinses in patients with chronic sinus disease
  148. The British Rhinological Society multidisciplinary consensus recommendations on the hospital management of epistaxis
  149. Initial assessment in the management of adult epistaxis: systematic review
  150. EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis
  151. Health care usage and quality of life reporting in chronic sinusitis patients
  152. The genetics of cholesteatoma. A systematic review using narrative synthesis
  153. Position paper on olfactory dysfunction
  154. Chronic rhinosinusitis and mood disturbance
  155. A randomised controlled trial of sodium citrate spray for non-conductive olfactory disorders
  156. Saline irrigation for allergic rhinitis
  157. Cochrane Corner: Extracts from The Cochrane Library: Intranasal Steroids for Chronic Rhinosinusitis
  158. CHronic Rhinosinusitis Outcome MEasures (CHROME), developing a core outcome set for trials of interventions in chronic rhinosinusitis
  159. Position paper on olfactory dysfunction
  160. Chronic rhinosinusitis and mood disturbance
  161. EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis
  162. A cross sectional analysis of a case-control study about quality of life in CRS in the UK; a comparison between CRS subtypes
  163. Intranasal sodium citrate solution improves olfaction in post-viral hyposmia
  164. A case-control study of medical, psychological and socio-economic factors influencing the severity of chronic rhinosinusitis
  165. Identifying the most important outcomes for systematic reviews of interventions for rhinosinusitis in adults: working with Patients, Public and Practitioners
  166. A cross sectional analysis of a case-control study about quality of life in CRS in the UK; a comparison between CRS subtypes
  167. Intranasal sodium citrate solution improves olfaction in post-viral hyposmia
  168. Topical and systemic antifungal therapy for chronic rhinosinusitis
  169. The value of a feasibility study into long-term macrolide therapy in chronic rhinosinusitis
  170. SNOT-22 in a control population
  171. Current practice in septal surgery and adjunctive turbinate reduction - A multisite experience in 226 consecutive cases
  172. A case-control study of medical, psychological and socio-economic factors influencing the severity of chronic rhinosinusitis
  173. Genetics of Cholesteatoma Project
  174. Short-course oral steroids alone for chronic rhinosinusitis
  175. Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis
  176. Different types of intranasal steroids for chronic rhinosinusitis
  177. Systemic and topical antibiotics for chronic rhinosinusitis
  178. Saline irrigation for chronic rhinosinusitis
  179. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis
  180. Chronic rhinosinusitis and mood disturbance
  181. Long term quality of life in patients with fungal sinus disease
  182. Identifying the most important outcomes for systematic reviews of interventions for rhinosinusitis in adults: working with Patients, Public and Practitioners
  183. Chronic rhinosinusitis: patient experiences of primary and secondary care - a qualitative study
  184. Anatomic findings in revision endoscopic sinus surgery: Case series and review of contributory factors
  185. Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis
  186. Systemic and topical antibiotics for chronic rhinosinusitis
  187. Saline irrigation for chronic rhinosinusitis
  188. Different types of intranasal steroids for chronic rhinosinusitis
  189. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis
  190. Short-course oral steroids alone for chronic rhinosinusitis
  191. Abstracts of the 2015 Annual Meeting 4-6 September 2015 Telford International Centre UK
  192. The impact of commissioning for rhinosinusitis in England
  193. Investigation of nasal diseases
  194. British Rhinological Society 14th Annual Meeting The Central Convention Centre, Manchester. 15th May 2015
  195. The burden of revision sinonasal surgery in the UK--data from the Chronic Rhinosinusitis Epidemiology Study (CRES): a cross-sectional study
  196. Authors’ response
  197. Hyposmia
  198. Assessing the sense of smell
  199. Cost-Effective Surgical Intervention in Chronic Rhinosinusitis
  200. Bilateral glossopharyngeal nerve palsy following tonsillectomy: a very rare and difficult complication of a common procedure
  201. Managing chronic rhinosinusitis and respiratory disease: a qualitative study of triggers and interactions
  202. Getting involved in ENT clinical research in the UK; how can the NIHR Clinical Research Network help?
  203. The Impact of Olfactory Disorders in the United Kingdom
  204. Chronic Rhinosinusitis and Mood Disturbance
  205. Management of CRSwNPs Surgically
  206. Olfactory Improvement and Decline in Patients with Posttraumatic Olfactory Dysfunction
  207. SNOT-22 in a Control Population
  208. Anatomy and Physiology of the Olfactory and Gustatory Systems
  209. Cerebrospinal Fluid Rhinorrhoea
  210. Ciliary Motility Disorders
  211. Clinical Governance and Audit
  212. Complications of Sinusitis
  213. Endoscopic Sinus Surgery and Complications
  214. Epistaxis
  215. European Position Paper on Rhinosinusitis and Nasal Polyps
  216. Facial Flaps, Scars, and Keloids
  217. Facial Fractures and Swelling
  218. Fungal Sinus Disease
  219. Headache and Facial Pain
  220. Medical Statistics
  221. Microbiology of ENT
  222. Olfactory and Gustatory Disorders
  223. Sinonasal Anatomy and Physiology
  224. Tumours of the Nose and Paranasal Sinuses
  225. Retronasal testing of olfactory function: an investigation and comparison in seven countries
  226. Using a passive coordinate measurement arm for motion tracking of a rigid endoscope for augmented-reality image-guided surgery
  227. Unilateral cacosmia: a presentation of maxillary fungal infestation
  228. When mealtime is the most dreaded moment of your day
  229. Pneumatisation of turbinates and paranasal sinuses in children: case report
  230. A double-blinded randomised controlled trial of the effects of sodium citrate on olfactory thresholds
  231. A double-blind randomised controlled trial of gloved versus ungloved merocel middle meatal spacers for endoscopic sinus surgery
  232. Epistaxis Secondary to an Oncocytoma of the Anterior Skull Base
  233. Skull base oncocytoma presenting as epistaxis: an unusual presentation of a rare tumour successfully managed with active surveillance
  234. A useful tool - systematic checklist for evaluating sinus scans
  235. Validation study of the “Sniffin’ Sticks” olfactory test in a British population: a preliminary communication
  236. A double-blind randomised controlled trial of gloved versus ungloved merocel middle meatal spacers for endoscopic sinus surgery
  237. Allergic fungal rhinosinusitis - a new staging system
  238. Allergic fungal rhinosinusitis - a new staging system
  239. Olfactory Dysfunction in Allergic Fungal Rhinosinusitis
  240. Selecting the Best Approach to the Frontal Sinus
  241. Nanomedicine in otorhinolaryngology: what does the future hold?
  242. Endoscopic management of inverted papillomas: long-term results, the St. Pauls Sinus Centre experience
  243. Endoscopic frontal sinusotomy-Preventing recurrence or a route to revision?
  244. Tumefactive fibroinflammatory lesion of the frontal sinus
  245. The Leicester semi-automated olfactory threshold test--a psychophysical olfactory test for the 21st century
  246. SUBJECTS AND METHODS
  247. Periorbital oedema and surgical emphysema, an unusual complication of a dental procedure: a case report
  248. Proximal Lacrimal Obstruction – A Review
  249. The superosmic phenomenon
  250. The Leicester Olfactometer
  251. Does methicillin-resistantStaphylococcus aureushave a significant role in the peri-operative course of patients undergoing rhinological surgery?
  252. ENT cases seen at a local ‘walk-in centre’: a one year review
  253. Does hormone replacement therapy in post-menopausal women have any effect upon nasal physiology?
  254. A brief history of olfaction and olfactometry
  255. The superosmic phenomenon
  256. Olfactory clearance: what time is needed in clinical practice?
  257. The Effect of Female Hormone Manipulation on Nasal Physiology
  258. R142: The Effects of Sensory Deprivation on Olfactory Thresholds
  259. R152: Olfactory Adaptation and Clearance in Clinical Practice
  260. Bronchiectasis and sino-nasal disease: a review
  261. What is the short term effect of perfumes on olfactory thresholds?
  262. Which variables matter in smell tests in the clinic?
  263. Does the benefit of adenoidectomy in addition to ventilation tube insertion persist long-term?
  264. Methicillin resistant Staphylococcus aureus: is it a problem for nasal surgery?
  265. Randomised-controlled study comparing post-operative pain between coblation palatoplasty and laser palatoplasty
  266. Comparison of Subjective Perception with Objective Measurement of Olfaction
  267. Response to Rachmanidou
  268. A double‐blinded randomized controlled trial of coblation versus conventional dissection tonsillectomy on postoperative symptoms
  269. Timing of tracheostomy in adult patients: Potential ramifications are alarming
  270. Variability of vascularity in nasal mucosa as demonstrated by CD34 immunohistochemistry
  271. Do our Noses Lead Us Away from the Scent?
  272. Superosmia: A New Vomeronasal Organ Mediated Phenomenon?
  273. A double-blinded randomized controlled trial of coblation versus conventional dissection tonsillectomy on post- operative symptoms
  274. Is there a role for more day-case septal surgery?
  275. Erratum
  276. Canalicular adenoma of the parotid gland
  277. Paediatric retropharyngeal abscess
  278. Which solvent for olfactory testing?
  279. Nasal physiological changes during pregnancy
  280. The effect of the steroid sex hormones on the nasal airway during the normal menstrual cycle1
  281. The effect of temperature, humidity and peak inspiratory nasal flow on olfactory thresholds
  282. Protocol biopsy of the stable renal transplant: a multicenter study of methods and complication rates
  283. Subjects and methods
  284. Hyposmia